<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the present study was to confirm the histopathological features of aggressive B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Papua New Guinea (PNG)-an EBV endemic region </plain></SENT>
<SENT sid="1" pm="."><plain>The immunophenotypic features and expression of EBV-encoded proteins and <z:chebi fb="40" ids="33697">RNA</z:chebi> in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were analyzed in 21 PNG children, and compared to the corresponding features of 17 Japanese children with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Histological diagnosis of the <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from the PNG children was <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> in nine patients; atypical Burkitt/Burkitt-like variant of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLL</z:e>) in three; diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) in four; and B-lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (B-LBL) in five </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from the PNG children had a high positive rate on EBV-<z:chebi fb="40" ids="33697">RNA</z:chebi> in situ hybridization (EBV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>; 66.7%) </plain></SENT>
<SENT sid="4" pm="."><plain>With regard to the histological typing, 10 of 12 patients (83%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLL</z:e>, one of four (25%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, and three of five (60%) with B-LBL were positive for EBV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The findings of EBV-positive B-LBL were surprising because it is commonly considered that lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is not associated with EBV </plain></SENT>
<SENT sid="6" pm="."><plain>EBV positivity was not detected in the 12 Japanese patients who were available for the EBV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> evaluation </plain></SENT>
<SENT sid="7" pm="."><plain>It is concluded that it is possible that a proportion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and B-LBL besides <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLL</z:e> are associated with EBV in endemic region </plain></SENT>
</text></document>